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 Abstract 
Regulating patients’ access to healthcare has been used in several countries as a way of controlling 
patients’ consumption levels. In some countries, provider choice is directly limited through legal regu-
lations such as gatekeeping, whereas in other countries patients’ behavior is primarily governed by 
financial incentives like co-payments to doctor visits. However, empirical studies, mostly conducted in 
the United States, do not provide a clear answer whether institutional access regulations actually ac-
complish a reduction of used health services. The objective of this paper is to assess the impact of 
access regulations on healthcare utilization in a cross-national framework comparing eleven European 
countries. While access restrictions are assumed to have an effect on the overall level of utilization, 
they can also have an impact on the equity of utilization between different socio-economic groups. Our 
analyses combine institutional indicators on the country level and number of doctor visits on the micro-
level from the first wave of SHARE. The results show that access regulations and especially gatekeep-
ing systems are associated with a lower level of overall service usage. Gatekeeping systems also 
reduce inequity in specialist visits across groups with different levels of education. Contrary to theo-
retical expectations but in line with earlier studies cost sharing could not be related to inequity patterns 
across income groups.  
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Introduction1 
Universal access to healthcare is a governing principle of European health systems. In fact, opposed 
to most other countries, including the United States, European countries have followed through on the 
promise of universal access to healthcare for their populations (Freeman 2000; OECD 2004). Begin-
ning in the 1950s not only in National Health Service but also in Social Health Insurance type of sys-
tems establishing equal access to healthcare for all citizens was a primary policy goal in health poli-
tics. As a result, Western European countries gradually extended coverage and benefits. However, 
following the oil price shocks of the 1970s and increasingly since the 1990s, controlling expenditures 
has dominated the political debate. This led to the realization that universal access does not mean that 
all types of care are freely available at customer’s demand. Having experienced a steep increase of 
health expenditure today there is high consensus among policy makers and researchers alike that 
access to healthcare has to be regulated in order to keep it affordable (Leidl 1999; Gulliford et al. 
2003; Breyer et al. 2005).  
There are multiple options for regulating consumption in the field of healthcare such as the determina-
tion of the overall budget or setting physicians’ remuneration (Saltman and Busse 2002). In the last 
two decades, however, there has been a trend towards applying micro-economic regulation instru-
ments which aim to directly influence patients’ access and care-seeking behavior. The two instruments 
that have been first of all used for patient regulation are gatekeeping and cost sharing.  
Gatekeeping systems regulate the use of services by transferring responsibility for decisions about 
care to general practitioners, thus limiting individuals access to more expensive specialists (Franks et 
al. 1992; Scott 2000; Wasem et al. 2003; Pihl et al. 2005). Cost sharing, on the other hand, reintro-
duces price mechanisms in third party payer systems in order to encourage patients to use healthcare 
in a more conscious way and thus more efficiently (Ros et al. 2000; Thomson and Mossialos 2004).  
Since cost containment is at the top of the political agenda, efficiency considerations dominate the 
political discussions on instruments that regulate access to care. This, however, neglects the fact that 
such measures also have implications regarding equity of access (Saltman and Busse 2002). Equity is 
based on the notion that there is “a basic human need for care” and that consequently differences in 
care utilization are only ethical when they are based on differences in need (Hanratty et al. 2007). 
Even though most European health systems have some private arrangements that provide superior or 
quicker care, the universal system in which the total population is integrated is clearly oriented at the 
principle of equal access to care for equal need (OECD 2004; Hanratty et al. 2007).  
                                                     
1  The research reported here has received financial support from the German Research Foundation. We would 
also like to thank Gwyn Bevan, Anna Dixon, Monika Steffen, Zeynep Or, Carolyn Tuohy and further partici-
pants at The European Health Policy Group meeting in Dublin, April 17 & 18, 2008, Michaela Pfeifer, Monika 
Mischke and Nicole Biedinger for their helpful comments. 
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Gatekeeping can improve equity by standardizing the way healthcare is accessed. This way, people 
with a higher educational level do not have the opportunity to access specialists directly due to their 
informational advantage as it is the case in free access systems. Cost-sharing, in contrast, provokes 
concern for increased income inequity in utilization because the burden of co-payments hits lower 
income groups and the chronically ill disproportionally (Robinson 2002; Holst 2007). 
Differences in utilization across socio-economic groups are referred to as horizontal inequity but equity 
has also a vertical dimension. This refers to the distribution of care across groups with different need 
levels (“health status”). It points to the norm that resources should be devoted to those who have the 
highest need. Access regulations can also influence vertical inequity. By regulating access to care 
especially people with low need levels should be discouraged from entering the system and in particu-
lar from receiving specialist care.  
These considerations demonstrate the centrality of access regulations not only for the individual pa-
tient but also for the overall performance of health systems. Consequently, it is of importance to inves-
tigate whether the assumptions about the influence of access regulations on consumption levels and 
equity hold when tested empirically. Hence, the objective of this study is to analyze how access regu-
lations affect patterns of healthcare utilization along the following three research questions: 
(1) Is stronger regulation of access associated with a lower level of medical care utilization? 
(2) Does a strong regulation of access decrease or increase group differences in utilization due to 
education or income? 
(3) Does access regulation increase differences in the utilization of care by different health groups? 
Although the effects of access regulation have been analyzed before, the evidence derives mainly 
from studies conducted in the United States. However, due to the fragmentation and complexity of the 
U.S. system, it is questionable whether the results can be transferred to European health systems. 
Moreover, in the U.S. regulations are not set at a national or state level. Studies conducted in the U.S. 
are therefore small-scaled, often analyzing differences at the level of insurance companies. In Euro-
pean health systems, however access regulations are mostly institutionalized at the national level so 
that the largest part of the variance can be found between countries. Therefore, a cross-national com-
parative research design should provide more conclusive evidence for Europe. 
The empirical test of our hypotheses is based on the combination of macro-level institutional indicators 
and micro-level survey data of the first wave of SHARE, a comparative study of people over 50 con-
ducted in 11 European countries in 2004. Looking at the elderly is of special relevance for healthcare 
issues because higher age increases the probability of both acute and chronic diseases. These higher 
need levels make older people use healthcare most frequently of all population groups. Consequently, 
the effect of access regulations on utilization levels and costs depends very much on how older people 
react to or are affected by those.   
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In section 2, the theoretical relation between institutional access regulations and utilization is outlined. 
Section 3 gives an overview of instruments of access regulations, evidence of effects on utilization and 
a description of our measurement of legal regulations. A description of data, variables and method can 
be found in section 4. Section 5 includes results of the effects of access regulations on utilization lev-
els and within-country differences of utilization. Implications of our research regarding effects of ac-
cess regulations as well as for cross-national research in this area are discussed in the final section 6.  
Access and Utilization 
There are two lines of literature that investigate access to the healthcare system. Medical sociological 
approaches analyze the care-seeking decisions of individuals. Based on the finding that need or 
health status cannot explain the variability in using professional care across groups, they investigate 
which personal attributes influence the decision about seeking care. Comparative health studies also 
investigate access but on the level of nation states. Instead of looking at the individual, they identify 
characteristics of the health system that determine access. The purpose of this study is to contribute 
to a connection between both lines of literature. Therefore, this section concludes with a theoretical 
explanatory model which integrates access features on the individual and on the system level.  
Despite the vast literature on access, little agreement has been reached on how to define it (Oliver 
and Mossialos 2004). Andersen (1995) discriminates between “potential access”, which refers to indi-
vidual and institutional factors increasing the potential for entry into the health system, and “realized 
access”, which describes the factual utilization of services. In a nutshell: there is a difference between 
people having access and gaining access (Gulliford et al. 2003).  
The study of illness behavior in medical sociological research has stimulated several models and con-
cepts of what are the relevant influence factors in the care-seeking decision (Mechanic 1962; 
Pescosolido 1992; Young 2004). The dominant framework used in empirical studies analyzing health 
utilization is the behavioral model of health services use by Ronald Andersen (1973; 1974; 1995). 
According to the model, utilization measured by the type and frequency of services consumed is influ-
enced by factors on two different levels. On the individual level, variables such as predisposing and 
enabling factors as well as need are important; on the system level, resources and organization of 
healthcare are the relevant influence factors. System-level variables can have both a direct effect on 
utilization as well as an indirect effect via individual-level characteristics.  
The micro level components are defined as follows: 
• Predisposing characteristics include “demographic, social structural, and attitudinal-belief vari-
ables” which increase the probability of a person to enter the health system in case of sickness 
(Andersen and Newman 1973: 108). Consequently, these variables are present before the mani-
festation of any medical condition (Crets 1996). Examples for predisposing characteristics are: sex 
(demographic), education (social structural) and knowledge about disease (beliefs).  
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• Enabling variables are factors that make sources available to persons such as income and insur-
ance coverage and care available on the community level (Andersen and Newman 1973). These 
variables are not strictly located on the individual level but on the level of family, household or 
community (Aday and Andersen 1974).  
• Need is the most immediate factor or ultimate cause for healthcare use and therefore refers to “the 
actual illness problem that the individual is experiencing and the clinically judged severity of this 
illness” (Andersen and Newman 1973: 110). 
These factors are complemented by characteristics of the health delivery system: 
• Resources refer to the health personnel and material resources which are available in a health 
system. Both volume and geographical distribution of these resources play an important role for 
their accessibility (Aday and Andersen 1974).  
• Organization is further subcategorized into entry and structure. Factors that determine “entry” to 
care are for example travel and waiting time. “Structure” relates to the regulations that determine 
who treats the patient and how (Aday and Andersen 1974).  
Compared to earlier models, the strength of the Andersen model is that it emphasizes the influence of 
the care delivery system. It highlights the fact that not only individual need but also national health 
policy and institutional organization of healthcare are crucial determinants of service utilization. Ander-
sen (1995: 4) specifically stresses the point that the focus on global measures is fundamental because 
“to inform national health policy, global measures provide needed comprehensive indicators of the 
overall effect of policy change”.  
Despite the attention paid to characteristics of the health delivery system in this model, most empirical 
applications have been focused on the role of the individual level determinants (Gold 1998; Young 
2004). In their review of 139 empirical studies that referred to the behavioral model, Phillips and col-
leagues (1998: 571) come to the conclusion that only “few studies examined specific measures of the 
healthcare system or provider characteristics”. This indicates that the usefulness of Andersen’s model 
for assessing the role of macro-level and institutional variables for utilization of medical services is still 
understudied. The purpose of this study is to contribute to research in this field by filling this gap and 
strengthening the importance of health system features for utilization. 
Healthcare systems are often compared alongside institutional indicators, access being one of them. 
Often access is defined by the source of entitlement or the scope of coverage of the health system. 
This is a rather narrow definition of access because “even in systems of universal coverage, serious 
access barriers remain” (Busse et al. 2006: 4). 
More recent cross-country analyses focused on modes of regulations, respectively governance in 
healthcare systems (e.g. Moran 1999; 2000; Rico et al. 2003; Tuohy 2003; Burau and Blank 2006). 
These and further studies partly concentrate on regulations that also affect patients’ access to health-
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care services but do not explicitly focus on the question how access regulations might affect the utili-
zation of healthcare services.  
However, the focus in this study is not on modes of regulation but on specific regulatory mechanisms 
or instruments. According to Saltman and Busse (2002) these regulatory instruments are one of two 
dimensions in health sector regulation. On the one hand, there are the policy objectives that regulation 
is oriented at, such as equity and justice, economic efficiency and safety. On the other hand, there are 
“the health sector management mechanisms” which describe “the specific regulatory mechanisms 
through which decision-makers seek to attain the type of policy objectives (Saltman and Busse 2002: 
14). It is these more technical management mechanisms that are shown to influence the access of 
patients. Two crucial regulatory mechanisms which are assumed and shown to influence access to 
care are gatekeeping and cost sharing (Gervas et al. 1994; Groenewegen et al. 2002; Saltman and 
Busse 2002; Busse et al. 2006).  
The outlined mechanisms gatekeeping and cost sharing operationalize the dimension of organization 
of the delivery system in Andersen’s behavioral model. The second dimension of the health delivery 
system is the resources which capture the supply of services. There is also substantial variation on the 
supply of healthcare providers among European countries (Wendt and Kohl 2008). The density of 
providers determines the availability of services for patients. Other aspects of availability are waiting 
time or average travel distance (Beech 2003). However, there are no comparative data available on 
these issues that would allow comparing countries. Thus, this study focuses on provider density as a 
measurement of the availability of resources.  
In the first section, it was explained that access should be differentiated from utilization of care. This is 
done in this study based on the considerations by Andersen (1995) that all enabling factors for the 
entry into the system refer to having access, while gaining access is operationalized by the use of 
professional healthcare. The theoretical model assumes a causal relationship between both con-
structs: the more enabling factors exist the higher is the utilization of services. Utilization refers both to 
the frequency and type of care consumed. The focus is on the ambulatory sector, operationalized by 
the number of GP and specialist visits, because patients’ initiation is most important for these types of 
services compared to inpatient stays for instance.  
As been outlined in the description of the Andersen model, the enabling factors which determine ac-
cess exist on two levels. On the one hand, socio-demographic characteristics of the individual influ-
ence whether people seek professional healthcare. On the other hand, access regulations and pro-
vider supply on the macro-level determine the utilization of health services. Need is the proximate 
cause for utilization but the access variables moderate whether and which care is used. The focus in 
this study is on the effects of the institutional regulations on the level of healthcare utilization. More-
over, the interaction between country level variables and socio-demographics such as income and 
education is examined in order to investigate whether equity systematically covaries with these access 
regulations.   
Arbei tspapiere -  Mannheimer  Zentrum für  Europäische Sozia l forschung 113  
 - 6 -
Country Level 
• Gatekeeping 
• Cost Sharing 
• Provider Supply 
 
 
ACCESS 
Individual Level 
• Gender 
• Age 
• Education 
• Income 
• Employment Status 
• Location of Residence 
• Social Networks 
NEED 
UTILIZATION
GP Visits Specialist Visits 
Figure 1: Theoretical explanatory model 
 
 
 
 
 
 
 
 
 
 
 
 
Source: own depiction. 
Institutional Characteristics of the Delivery System 
In general, access restrictions are introduced because policy makers expect these to produce cost 
savings due to a more efficient utilization of resources. The existing lack of efficiency is attributed both 
to physicians’ initiation of diagnosis and treatment without additional health benefits and patients’ 
moral hazard behavior. Thus, access regulations can take either patients or providers as their starting 
point (Flynn et al. 2002). In this paper, we focus on regulatory instruments that try to influence patient 
behaviour either by legal restrictions such as gatekeeping or by financial incentives such as cost-
sharing arrangements. 
Gatekeeping 
Regulating access through institutional arrangements is commonly known as gatekeeping or family 
doctors systems (Wendt and Thompson 2004). These arrangements are expected to have positive 
effects both on efficiency and quality of care due to the informational superiority of the physician com-
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pared to the patient. First, it is assumed that by preventing unnecessary procedures utilization of ser-
vices and, consequently, costs can be reduced. Second, gatekeepers ensure that patients get the 
appropriate care in the secondary care market because “GPs usually have better information than 
patients about the quality of care available from secondary care providers” (Scott 2000). Additionally, 
gatekeeping GPs coordinate treatments for different illnesses and thus help to prevent unintended 
interaction effects of different treatments (Pihl et al. 2005).  
Although such hypotheses about the effects of gatekeeping on costs and utilization levels have re-
mained quite influential, the existing evidence on these aspects provides inconsistent or even contro-
versial results. Most of the studies about gatekeeping have been conducted in the U.S., where family 
doctor systems have been used in managed care arrangements for a long time. In a review of 19 U.S. 
studies, Robinson and Steiner (1998) find that some studies show a decreasing, some an increasing 
and some no effect of gatekeeping on utilitzation. Looking at more recent literature supports the con-
clusion of mixed results:  
A study conducted by RAND reports higher numbers of total physician visits in a gatekeeper health 
maintenance organization (HMO) than in the less regulated point-of-service plan (PPO) and no signifi-
cant differences with reference to specialist visits (Joyce et al. 2000). Schillinger and colleagues 
(2000), however, find no differences in primary care visits between people under gatekeeper ar-
rangements and people with free access but a significant reduction in specialist visits and both inpa-
tient and outpatient care after the introduction of gatekeeping for one group. A German study by Er-
linghagen and Pihl (2005) finds more total doctor visits when people state to have a general practitio-
ner they see regularly whereas a recent Swiss study (Schwenkglenks et al. 2006) reports a lower 
number of specialist visits under gatekeeping.  
Whereas cross-national studies examining the effects of access regulations on the overall level of 
utilization are rare, the relation between utilization differences across socio-economic groups and 
healthcare system features have been extensively investigated by the equity literature, especially by 
the work of van Doorslaer and colleagues (2000; 2004; 2006). In several cross-sectional analyses of 
the European Community Household Panel and additional national household surveys, van Doorslear 
and colleagues have investigated inequities in care utilization between income groups. One general 
observation in all studies is that poorer people are more frequent users of medical services. This rela-
tionship, however, disappears when controls for need are introduced because need or health status is 
unequally distributed over socio-economic groups. In line with this argument, we assume that both the 
analyses of utilization levels and within-country differences are only valid after controlling for health 
and other need variables. The general findings of the studies conducted by van Doorslaer and col-
leagues is that GP visits are characterized by (slight) pro-poor inequity, specialist visits, however, 
show strong pro-rich inequity (van Doorslaer and Masseria 2004; van Doorslaer et al. 2006). Inequity 
in medical specialist visits is found in nearly all countries irrespective of healthcare system characteris-
tics. In addition, they report that the main share of specialist inequity is found by analyzing whether 
people have seen a specialist at all and not in the conditional number of specialist visits. This brings 
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them to the conclusion that “inequity here is rather more patient-initiated than doctor-driven, although 
in countries with gatekeeping roles for GPs it may be GP-initiated. Notable exceptions to this rule are 
Austria and Denmark, where most of the inequity stems from the conditional number of positive visits” 
(van Doorslaer and Masseria 2004). 
Since the results by van Doorslaer and colleagues suggest that institutional characteristics have no or 
only modest effects on utilization levels of different income groups, in our analysis we will not only 
focus on income but also on education as well as on differences in the effect of health variables 
across countries. “Education” and “health status” have been selected for the following reasons: Many 
studies assume that institutional regulations automatically imply certain behaviors such as direct visit 
of specialists in countries with open access. However, the effect of these institutions is moderated by 
individual specific variables. It can be argued that for the use of specialist visits education should be 
crucial because the decision-making process for seeing a specialist includes a lot of knowledge and 
information seeking procedures in order to interpret conditions and decide upon the appropriate 
healthcare specialist. This means that higher educated people in countries with free access directly 
see a specialist more frequently because they feel competent to make their own decision about the 
appropriate care. Less educated people, on the other hand, might even in countries with no restricted 
access first visit a GP that takes responsibility for the decision-making process. In countries with re-
stricted access, higher-educated people may still have more specialist visits because they can put 
more pressure on their GPs but the effect should be smaller than in the free access countries. 
Access regulation should also create different utilization patterns of different health groups. Restrictive 
regulations intend to increase efficiency, in other words, reduce moral hazard behavior by denying 
(specialist) care to people without according need. This means that in countries with less restrictive 
regulations the difference in the probability of doctor visits of groups with different health status should 
be much smaller than in countries where strong regulations prevent healthy people from receiving 
extensive care. As a result, the effectiveness of access regulations cannot only be seen in a reduction 
of the overall utilization levels but more specifically in lower utilization levels of people in good health.  
The previous considerations can be summarized with the following three hypotheses.   
H1: The stronger gatekeeping is in a country the lower is the overall utilization level. 
H2: The stronger gatekeeping is in a country the smaller are the differences in the utilization of spe-
cialist care between groups of people with different levels of education. 
H3: The stronger gatekeeping is in a country the lower are the differences in utilization between 
groups with different health status.  
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Cost Sharing 
In general, cost sharing is defined as private payments by patients that “contribute to the cost of 
healthcare at the point of use” (Thomson and Mossialos 2004: 19). This is in contrast to insurance 
contributions which are paid independent of actual use (Holst 2007). 
Table 1: Forms of cost sharing 
Form Definition 
Co-payment The user pays a fixed (small) fee (flat rate) per item or service. 
Co-insurance The user pays a fixed or variable proportion of the total cost, with the insurer 
paying the remaining proportion. 
Deductible The user pays a fixed quantity of the costs, with any excess borne by the 
insurer; deductibles can apply to specific cases or a period of time.  
Source: (Thomson and Mossialos 2004: 19; Holst 2007: 24) 
 
Both co-payments and co-insurance imply that for each service used a certain amount has to be 
paid. For co-payments this amount is fixed for a specific service such as 5 € per prescription while co-
insurance specifies payment at a certain percentage. These two forms are dominant in European 
healthcare systems. The third type of cost sharing, the deductible, is exclusively used in Switzerland. 
It means that people have to pay all healthcare costs up to a certain limit. In Switzerland the deducti-
ble is 200 € and after it is exceeded a co-insurance rate of 10% applies (van Kemenade 2007). The 
effect of cost sharing depends not only on its level but also on whether it is covered by private insur-
ance and the protection mechanisms installed. In Switzerland it is legally prohibited to cover cost-
sharing by private insurance, ensuring that the effect on consumption is not undermined. In other 
countries, however, co-payments can be covered by private insurance (Tiemann 2006). In France and 
Belgium, for instance, where relatively high co-insurance rates apply, the main share of the population 
has private insurance, called “mutuelles”, that cover these extra costs (Couffinhal 2003)2. The effect of 
cost-sharing on consumption also depends on other protection mechanisms and exemptions. These 
are implemented in most healthcare systems to protect groups with specific risks such as the poor, the 
elderly or chronically ill persons. The protection can take the form of exemptions, reduced rates or 
annual payment caps. 
The hypothesized effects of cost-sharing on patients’ consumption behavior are based on the notion of 
moral hazard, a concept developed in neoclassical economic theory. Moral hazard refers to the effect 
of insurance on consumption behavior of patients (Zweifel and Manning 2000), namely that it encour-
ages utilization which “exceeds socially beneficial levels” (Thomson and Mossialos 2004: 20). Insur-
ance is used here in the broader sense of having a third party who pays for consumed health services. 
                                                     
2  In France, about 85% of the population have private health insurance covering co-insurance of the public 
system. However, coverage of private insurance differs with employment status and income. In the working 
population for example, coverage is almost 90% while only 60% of the unemployed have private insurance 
(Couffinhal 2003).  
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This can be any type of insurance but also coverage by a national health system. For the individual, 
being covered by insurance creates a lower threshold for utilization because they do not have to pay 
for the consumed services. They might even not be aware of the price of the goods and services they 
consume (Breyer et al. 2005). In social insurance systems, the insured might also think that because 
they have paid their contributions, they should consume services to justify their expenses on health 
insurance. Through cost-sharing, prices are reintroduced in the third-party payer system, making peo-
ple think more about utilization decisions, especially in cases of minor illnesses (Thomson and Mos-
sialos 2004; De Graeve et al. 2006). This is supposed to encourage more restrictive use of care result-
ing in lower levels of utilization. 
Evidence on the effects of cost-sharing abounds but remains unsatisfactory because the studies are 
hardly comparable (due to different insurance arrangements, time horizons and estimation methods) 
and contain several methodological problems. Since existing evidence has been reviewed several 
times, in this section only some of the most recent reviews of the effects of cost-sharing are dis-
cussed.  
The reference point of all reviews about cost sharing is still the RAND Health Insurance Experiment 
which was conducted from 1974 to 1982 in the U.S. Its significance is due to the fact that it has been 
the only large-scale randomized experiment ever conducted: 6,000 people were randomly assigned to 
insurance plans with different cost sharing regulations. The main result of this study is “that the use of 
medical care declines as patient cost sharing increases“ (Louckx 2002: 190). This reductive effect of 
cost-sharing was confirmed by almost all previous and subsequent studies, irrespective of the ar-
rangement and country the studies were conducted (Cherkin et al. 1989; Rice and Morrison 1994; 
Zweifel and Manning 2000; Robinson 2002; Thomson and Mossialos 2004; De Graeve et al. 2006; 
Holst 2007). While the effectiveness of cost sharing in terms of simply reducing the number of visits is 
widely seen as a proven fact, there is much less consensus on the question how cost sharing affects 
health and whether its effects differ between different types of services, services with different neces-
sity, different income groups and groups with different health status.  
Efficiency 
As was hypothesized in the theoretical disquisition on cost sharing, micro-efficiency would imply that 
utilization for less adequate or necessary services decreases more than utilization of necessary diag-
nosis and treatment. The RAND study shows that cost sharing reduces both the utilization of inappro-
priate as well as appropriate care, including preventive services (Robinson 2002). This result casts 
doubt on the idea of increased micro-efficiency of cost-sharing. Up to now, no study has shown that 
this reduction of health services transforms into reduced health. According to results from the RAND 
health experiment, there are no differences between groups with different insurance arrangements for 
most health measures except for “diastolic blood pressure, corrected vision and the risk of dying for 
those who were at elevated risk” (Rice and Morrison 1994: 244). RAND excluded people over 65 and 
the short duration of the study (five years) thus delimiting the efficiency of modeling on long-term 
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health effects, especially for the elderly and the chronically-ill cannot be estimated (Rice and Morrison 
1994; Holst 2007). If there was a deteriorating effect on health, the expectation of macro-efficiency or 
long-term cost-savings of cost sharing might also be questionable.  
In terms of inequity, the majority of the studies found that poor people reduced their utilization of ser-
vices significantly more than the rest of the population (Rice and Morrison 1994; Zweifel and Manning 
2000; Thomson and Mossialos 2004). The effect depends both on the coinsurance rate/level of co-
payment and existing protective instruments (Thomson and Mossialos 2004). A second group that 
seems to be disproportionally burdened are the sick or chronically ill. Several studies demonstrate that 
high users and people with low health status decrease their service use more than others (Cherkin et 
al. 1989; Zweifel and Manning 2000; De Graeve et al. 2006).  
While nobody challenges the fact that cost sharing reduces utilization, many scholars are concerned 
about unintended effects. These can be as potential decreases in health due to non-received preven-
tive and curative services or increasing inequity due to the disproportionally high burden of lower-
income people and the chronically ill. Finally, scholars argue that the high administrative costs of user 
charges might neutralize existing cost-savings (Robinson 2002; Thomson and Mossialos 2004; Wendt 
2006; Holst 2007).  
Although it was stated in the previous section that the ability to pay is less important in European 
countries, cost sharing qualifies or challenges this assumption of universal access for certain coun-
tries. Where cost sharing plays an important role, income might reemerge as a significant influence 
factor of healthcare use. 
H4: The higher cost sharing is in a country, the lower is the overall level of utilization. 
H5: The higher cost sharing is in a country, the higher is utilization inequality between income groups. 
Institutional Indicators  
While gatekeeping is often measured as a dichotomous variable the definitions already indicated that 
gatekeeping can be implemented to different degrees. This is why in this paper an index is used as a 
continuous measure where each country can be located at based on the extent of access regulation 
(see Table 2). According to Wasem and colleagues (2003), gatekeeping exists when three necessary 
characteristics are present: First, people have to register with a GP for a certain amount of time. Sec-
ond, the payment system of physicians is based on capitation, and third secondary care can only be 
accessed with a GP referral. 
The first component “registration with a GP” captures whether people are forced to set their choice of 
general practitioner for a certain period of time. This indicator is one of the constitutive elements of 
“gatekeeping” which has been widely used in previous studies for assessing access regulations (e.g. 
Gervas et al. 1994; Ettelt et al. 2006; Wendt and Kohl 2008). Registering with a GP transfers respon-
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sibility for the coordinating function to a specific agent and prevents at the same time that people ob-
tain a second opinion, a phenomenon described as “doctor shopping” (Saltman 1994)3. In their policy 
brief of the European Observatory, Ettelt and colleagues (2006) demonstrate that the restrictiveness of 
GP registration depends on whether there is a defined area in which the GP has to be chosen. As 
shown in table 1, countries which do not have GP restrictions also do not restrict the area of choice. 
The combination of GP registration and limitation of geographic area is found in Denmark, Italy, and 
Spain, which can be defined as the “pure gatekeeping types”. The Dutch gatekeeping system and the 
Swedish modified gatekeeping system that is heavily based on financial incentives do not restrict 
choice geographically.  
The second of Wasem’s components relates to the payment by capitation. Under capitation schemes, 
doctors receive a fixed amount for each patient on their list independent of services provided. This 
type of payment is most often used for gatekeepers because “it motivates doctors to practice in a way 
that encourages patients to join their list” (Or 2000: 16).  
The last characteristic of gatekeeping according to Wasem and colleagues (2003) reflects the control 
of access to the secondary care market which includes specialists in private practices and health cen-
ters as well as specialists working in hospital outpatient departments4. Access to specialists can be 
regulated in three ways. The most restrictive option is that patients need a referral in order to access 
secondary care. In this case, there are no legal alternatives to see a specialist without a referral or 
paying the whole fee out of pocket5. In some countries, people can use a referral but also skip the 
referral system by accepting a higher co-payment (Ettelt et al. 2006). This procedure is established in 
Austria, Belgium, and Sweden. While in Austria the specialist visit is free when referred, in Sweden 
and Belgium a higher than the regular co-payment is charged when people skip the referral system. In 
Sweden for example people pay 24 € for a specialist visit without a referral but only 13 € when being 
referred. These “additional co-payments” have to be distinguished from the usual cost sharing ar-
rangements which are not tied to referral systems. These are discussed in the next chapter. The least 
restrictive pole on this indicator is represented by France and Switzerland where people have free (in 
the sense of not-referral based) access to specialist care.  
For introducing these indicators into the statistical analysis, an additive sum index was created that 
indicates the extent to which gatekeeping has been established. Since the legal regulation index (LRI) 
is later combined and compared to the cost sharing index, it is used in a rescaled form that ranges 
                                                     
3  How much GP registration restricts patients’ freedom also depends on other factors such as the duration of 
registration and the regulations for the case people want to switch their GP. Collecting this information in a 
systematic way for all countries, however, was not possible.  
4  Access to inpatient care was not included for two reasons. First, hospital stays are not used as a dependent 
variable and secondly, irrespective of system type in all countries direct entrance to inpatient care, except for 
cases of emergency, is restricted. This indicator would therefore show no variance across countries. 
5  De facto, there are alternatives in some of these countries. In Spain, for example, many people enter care 
through the emergency entrance of hospitals because waiting times for specialist visits take very long (Rico 
and Sabes 2000). Unfortunately, the quantitative importance of these attempts to bypass the regular system is 
not sufficiently documented and therefore it could not be included in the analysis.  
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from 0 to 10, shown in the last column. The LRI shows that there is considerable variance in the re-
strictiveness of the system beyond the gatekeeper system dichotomy that has formerly been used. 
Table 2: Legal Regulation Index 
Country GP        
Regist-
ration 
Geo-
graphic 
Rest-
riction 
GPs        
paid by     
capitation 
Access to 
specialists
Access to 
outpatient 
care in 
hospital 
LRI LRI re-
scaled   
(0-10) 
Austria1 -- -- + skip & pay skip & pay 3 4.3 
Belgium2 -- -- -- skip & pay skip & pay 2 2.9 
Denmark3 + + + referral referral 7 10.0 
France4 -- -- -- free free 0 0.0 
Germany5 -- -- -- free referral 2 2.9 
Greece6 -- -- -- free free 0 0.0 
Italy7 + + + referral referral 7 10.0 
Netherlands8 + -- + referral referral 6 8.6 
Spain9 + + -- referral referral 6 8.6 
Sweden10 + -- -- skip & pay skip & pay 3 4.3 
Switzerland11 -- -- -- free free 0 0.0 
Note: Coding for index construction -- = 0; + = 1; free = 0; skip & pay =1; referral = 2. 
Sources: 1(Hofmarcher and Rack 2001; Hofmarcher 2003; Rosian et al. 2003; Schneider et al. 2004); 2(Kerr and 
Siebrand 2000); 3(Vallgarda et al. 2001); 4(Or 2002; Sandier et al. 2004); (Alber and Bernardi-Schenkluhn 1992); 
5(Alber and Bernardi-Schenkluhn 1992; Busse and Riesberg 2000; Bundesausschuss der Ärzte und Krankenkas-
sen 2003; Rosenbrock and Gerlinger 2006); 6(Tragakes and Polyzos 1996; Davaki and Mossialos 2006); 
7(Hohmann 1998; Donatini et al. 2001); 8(den Exter et al. 2004; Ettelt et al. 2006; Tiemann 2006); 9(Rico et al. 
2000), 10(Hjortsberg and Ghatnekar 2001; Tiemann 2006); 11(Minder et al. 2000)  
 
Cost sharing has been considered a central institutional feature which shapes patients’ access and 
provides an explanation for cross-national differences in equity of care (Thomson and Mossialos 
2004). However, previous work did not go beyond the comparative description of cost sharing ar-
rangements in Europe (Ros et al. 2000; Robinson 2002; OECD 2004). The regulations are usually 
presented in a country specific way (e.g. fixed amounts in case of co-payment, percentage in case of 
cost-sharing) without taking into account different validation periods and application criteria. However, 
on this basis the financial burden patients’ face cannot be compared across countries. Using cost 
sharing as an explanatory factor, as intended in this study, requires instead a single well-defined 
measurement on which all countries can be located. A financial incentive indicator is proposed which 
combines information on out-of-pocket payments, cost sharing as well as protection mechanisms.  
The indicators used by previous studies are cost sharing of GP visits, of specialist visits, of pharma-
ceuticals, of inpatient care and of dental care (Ros et al. 2000; Robinson 2002; OECD 2004; Thomson 
and Mossialos 2004). For our analyses, we chose only two of these indicators, cost sharing of GP and 
specialist visits, because they have the most direct effect on the number of doctor visits (including both 
GP and specialist visits). When people consider seeing a doctor, they are aware that these costs ap-
ply with absolute certainty. Consequently, these costs can be considered to have an impact on pa-
tients’ decision-making. 
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The purpose of collecting these indicators is to develop an index which reflects the financial strain that 
results from cost sharing arrangements. The index is to be created in a way that all countries can be 
assigned a specific position on it. Therefore, we tried to obtain, if possible, the absolute value that 
people pay for a doctor visit. In order develop a uniform measurement for cost sharing these absolute 
values had to be transformed into a different scale due to the following reasons. First, the amount 
does not adequately reflect the qualitatively important difference between having a co-payment and 
not having a co-payment. For instance, the difference between 0 and 3 Euro is much more significant 
than the one between 3 Euro and 6 Euro. The first difference determines whether actual use of care is 
connected with costs for the patient or available free of charge while the second difference is only a 
difference in the amount to be paid. The second reason is that for Switzerland and Italy an average 
amount could only be approximated. Finally, the absolute amounts for one doctor visit can be mislead-
ing because they do not take the different periods of validation and the effects of cost sharing maxi-
mums into account. In Austria, for instance, an initial charge of 3.63 Euros is paid at the first doctor 
visit but this voucher is valid for one quarter of the year (independent of the number of visits) as op-
posed to Belgium where 4.54 Euros are charged for each visit. Sweden, on the other hand, has an 
arrangement where co-payments for doctor visits are relatively high but combined with a low out-of-
pocket cap that is reached after very few visits.  
The strategy chosen for incorporating this complexity in the index was to develop two theoretical sce-
narios for each indicator. These scenarios are supposed to capture the impact of cost sharing on both 
persons with only few visits (“low user”) and people with a high frequency of visits (“high user”). The 
low user scenario reflects the costs incurring at the first visit, the high user scenario is set at 10 GP 
and 5 specialist visits. 
Even though it is possible to work just with these four scores, it might result in a misleading interpreta-
tion of the differences between countries when the protection mechanisms are not taken into account 
(Mossialos and Thomson 2003). However, only Ros and colleagues (2000) collected information on 
exemption rules for the poor, the chronically ill, older people as well as on co-payment ceilings. The 
idea behind the collection of these indicators is that the impact of cost-sharing is reduced the more 
protection mechanisms are installed. In order to model this, a protection index was created which is 
used as a weight for the cost-sharing index scores. The score ranges from 0 to 1. 
The final financial incentive indicator is now created by using the scores for the four scenarios, the 
weight constituted by the protection index, and the out-of-pocket payments per capita. The general 
logic of the index construction is addition. All indicators are scaled from 0 to 2 so that they represent 
equal shares in the index. The effects of cost-sharing depend highly on the exemptions and other pro-
tection mechanisms installed. In a country such as Italy, where in most provinces the poor, chronically 
ill and older people are exempt from cost sharing, looking only at the institutional scores would overes-
timate the average financial strain resulting from the arrangement. Therefore, the index created by 
adding the scores for the four scenarios is weighted by multiplying it with the protection index. Illus-
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trated on the Italy example, two zeros and two twos are added up to 4.0 which is multiplied by 0.6 
resulting in 2.4 (see Table 3).  
As a final step the out-of-pocket payments (OOP) per capita are added. For this procedure OOPs 
were also rescaled to a range from 0 to 2. This was done under the assumption that Switzerland 
should receive the maximum value. The according transformation rule is therefore to divide the origi-
nal OOP-value by 1,000 and then to multiply the resulting value by 1.27. The out-of-pocket payments 
are not weighted since the effects of the protection mechanisms are already included in this aggregate 
measure which reflects the quantitative effect of all regulations. The mathematical rule for the index 
creation can consequently be written as: 
FII = [(GP1 + GP10 + SP1 + SP5)*Weight] + OOP 
Table 3: Creation of Financial Incentive Index (FII) 
Country GP 1 Score 
GP 10 
Score 
SP 1  
Score 
SP 5 
Score 
Protection 
Index 
(Weight) 
Out-of-
Pocket 
Payments 
(OOP) 
Financial 
Incentive 
Index   
(FII) 
 
FII re-
scaled    
(0-10) 
Austria1 1 1 1 1 0.7 0.70 3.5 4.2 
Belgium2 1 1.2 1.0 1.1 0.7 0.90 3.9 4.6 
Denmark3 0 0 0 0 0.5 0.69 0.7 0.8 
France4 1.1 1.2 1.1 1.1 0.7 0.30 3.5 4.2 
Germany5 0 0 0 0 0.5 0.48 0.5 0.6 
Greece6 0 0 0 0 0.5 0.92 0.9 1.1 
Italy7 0 0 2 2 0.6 0.62 3.0 3.6 
Nether-
lands8 
0 0 0 0 0.5 0.30 0.3 0.4 
 
Spain9 0 0 0 0 0.5 0.50 0.5 0.6 
Sweden10 1.4 1.4 1.4 1.3 0.8 0.54 4.9 5.8 
Switzer-
land11 
2 2 2 2 0.8 2.00 8.4 10.0 
 
Sources: 1(Hauptverband der Österreichischen Sozialversicherungsträger 2003; Schneider et al. 2004; Hofmar-
cher and Rack 2006), 2(Kerr and Siebrand 2000; Schneider et al. 2004; De Graeve et al. 2006), 3(Vallgarda et al. 
2001), 4(Couffinhal 2003; Schneider et al. 2004), 5(Schneider et al. 2004; Pfaff and Kern 2005), 6(Tragakes and 
Polyzos 1996; OECD 2004), 7(Hohmann 1998; Donatini et al. 2001; Giannoni-Mazzi 2003), 8(den Exter et al. 
2004; Tiemann 2006), 9(Rico et al. 2000), 10(Anell and Svensson 1999; Schneider et al. 2004; Tiemann 2006), 
11(Minder et al. 2000; van Kemenade 2007). 
 
Since we hypothesized that cost sharing and gatekeeping could have similar effects on the overall 
level of utilization they might work as functional equivalents. In Denmark and the Netherlands, for in-
stance, the design of the legal gatekeeping systems is supposed to reduce the consumption of spe-
cialist care. However, high co-payments for specialist visits as they are established in Switzerland or 
Sweden could have the same effect. Consequently, a measurement that is able to explain most of the 
variance across countries should include both types of regulations. Therefore a regulation index (RI) 
was created by adding the legal regulation index and the financial incentive index in their rescaled 
version with a range from 0 to 10 (see table 4). 
RI = FII + LRI 
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Table 4: Creation of Regulation Index (RI) 
Country FII rescaled    
(0-10) 
LRI rescaled   
(0-10) 
Regulation Index 
(RI) 
Austria 4.2 4.3 8.5 
Belgium 4.6 2.9 7.5 
Denmark 0.8 10.0 10.8 
France 4.2 0.0 4.2 
Germany 0.6 2.9 3.5 
Greece 1.1 0.0 1.1 
Italy 3.6 10.0 13.6 
Netherlands 0.4 8.6 8.9 
Spain 0.6 8.6 9.2 
Sweden 5.8 4.3 10.1 
Switzerland 10.0 0.0 10.0 
 
The respective hypothesis for the regulation index is then: 
H5: The higher overall degree of access regulation the lower is the overall utilization level.  
Figure 2 gives an overview how the countries score on these indices. We can see that to some extent 
there is an inverse relationship between gatekeeping and cost sharing. In some countries such as 
Denmark, Spain and the Netherlands access regulation almost exclusively relies on gatekeeping ar-
rangements while in Switzerland and France regulation is formed only by financial incentives. Austria, 
Belgium, Italy and Sweden have a mix of gatekeeping regulations and cost sharing. They could be 
called modified gatekeeping systems because they mix legally free access to specialists with financial 
incentives to first see a GP. Overall, the countries with the highest level of regulation are Italy, Den-
mark, Sweden and Switzerland while Greece, Germany and France build the bottom end. The strong-
est gatekeeping countries are Denmark, Italy, Spain and the Netherlands while the countries with the 
highest cost sharing levels are Switzerland, Sweden and Belgium. Greece has an exceptionally low 
level of regulation, however, access to care is restricted by ways that are not covered by these indica-
tors such as informal payments (Davaki and Mossialos 2006).  
Figure 2: Overview of regulation indices by country 
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Source: own data.  
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Data and Method 
Data  
The data that we use for analyzing utilization is the first wave of the Survey of Health, Ageing and 
Retirement in Europe (SHARE) which was carried out between April and October 20046. The survey 
contains valid information, for the purposes of this paper, on 11 European countries and Israel7. The 
population that is covered by SHARE is people over 50 and their partners who were interviewed inde-
pendent of their age. As we are interested in inferences to a population of older individuals, we re-
stricted our analysis sample to people aged 50 and older which means that all partners being younger 
have been excluded (N = 26,808). Table 5 shows the number of respondents per country for our 
analysis sample which ranges from 908 in Switzerland to 3639 in Belgium.  
Table 5: SHARE 2004, sample size by country 
Country N 
Austria 1,825 
Belgium 3,639 
Denmark 1,583 
France 2,905 
Germany 2,894 
Greece 2,625 
Italy 2,463 
Netherlands 2,772 
Spain 2,274 
Sweden 2,920 
Switzerland 908 
Total 26,808 
 
Variables 
Table 6 gives information about the variables used in the following analysis. As dependent variables 
we used the number of total doctor visits, the number of GP visits and the number of specialist visits. 
Measurement of annual medical doctor utilization was based on the question “When you think about 
                                                     
6  The SHARE data collection has been primarily funded by the European Commission through the 5th frame-
work programme (project QLK6-CT-2001- 00360 in the thematic programme Quality of Life). Additional fund-
ing came from the U.S. National Institute on Ageing (U01 AG09740-13S2, P01 AG005842, P01 AG08291, 
P30 AG12815, Y1-AG-4553-01 and OGHA 04-064). Data collection for wave 1 was nationally funded in Aus-
tria (through the Austrian Science Foundation, FWF), Belgium (through the Belgian Science Policy Office), 
France (through CNAM, CNAV, COR,  Drees, Dares, Caisse des Dépôts et Consignations et le Commissariat 
Général du Plan) and Switzerland (through BBW/OFES/UFES. The SHARE data collection in Israel was 
funded by the U.S. National Institute on Aging (R21 AG025169), by the German-Israeli Foundation for Scien-
tific Research and Development (G.I.F.), and by the National Insurance Institute of Israel. Further support by 
the European Commission through the 6th framework program (projects SHARE-I3, RII-CT- 2006-062193, 
and COMPARE, CIT5-CT-2005-028857) is gratefully acknowledged. For methodological details see Boersch-
Supan and Juerges (2005). 
For an overview over the survey contents, see Börsch-Supan et al. 2005. This document and further informa-
tion is available from the website http://www.share-project.org/. 
7  Israel was excluded from the analysis due to lack of available institutional indicators. 
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your care during the last twelve months about how many times in total have you seen or talked to a 
medical doctor about your health? Please exclude dentist visits and hospital stays, but include emer-
gency room or outpatient clinic visits.“ The following question specified the number of GP visits: “How 
many of these contacts were with a general practitioner or with a doctor at your healthcare center?“. 
The number of specialist visits is not directly measured by the survey. We subtracted the number of 
GP visits from the total number of doctor visits and used the residual as number of specialist visits. 
This procedure certainly increased the measurement error but was the only way for us to include 
number of specialist visits in our analysis. 
Table 6: Description of Variables Used in Analysis. 
Variable Description 
Dependent Variables  
Alldocv Number of medical doctor visits in the last 12 months. 
Gpdocv Number of general practitioner visits in the last 12 months. 
Spdocv Number of specialist visits in the last 12 months. 
Independent Variables (Micro-Level) 
Male Gender: male=1; female=0. 
Cage Centered age. 
Cage2 Centered age squared. 
Cagemale Interaction between centered age and male. 
Cage2male Interaction between centered age squared and male. 
Isced0t2 Education, ISCED 0-2 = 1; otherwise = 0. 
Isced3a4 Education, ISCED 3-4 = 1; otherwise = 0. 
Isced5a6 Education, ISCED 5-6 = 1; otherwise = 0. 
Chronic Number of chronic diseases. 
Spheu Self-rated health status, ranging from very good = 1 to very bad =5. 
Employed Employed or self-employed = 1; otherwise = 0. 
Netinc Log of Household Total Net Income, standardized by dividing it through square 
root of household size, PPP-adjusted. 
Urban  Location of the main residence, big - large city =1; otherwise = 0.  
Livtog Living with partner/spouse = 1; otherwise = 0.  
Hsize Household size: Number of persons living in household. 
Independent Variables (Macro-Level) 
Ri Regulation Index, ranging from 0 = very low to 20 = very high.  
Lri Legal Regulation Index, ranging from 0 = very low to 20 = very high. 
Fii Financial Incentive Index, ranging from 0 = very low to 20 = very high. 
Numall Number of physicians per thousand inhabitants. 
Numgp Number of general practitioners per thousand inhabitants. 
Numsp Number of specialists per thousand inhabitants. 
 
Variation in the number of physician visits is explained using need variables such as self-rated health, 
age, etc and other factors that influence the availability, e.g. urban. The variables of interest to assess 
differences in equity are education which was operationalized by the ISCED coding, income and 
health status. Due to no or very few observations in certain categories of the ISCED variable in some 
of the countries, we collapsed several categories into three dummies. The first dummy includes the 
ISCED-Groups 0, 1 and 2 which represent pre-primary, primary and lower secondary education. In the 
analysis, they are used as the reference groups. Isced3a4 contains people with a maximum level of 
upper secondary and post-secondary but not-tertiary education. The latter category consists of several 
options such as evening schools and vocational training. The people with a university or other college 
degree and Ph.Ds are included in Isced5a6.  
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As income measure we use an imputed variable of Household’s Total Gross Income provided by 
SHARE and transformed this into net income by subtracting an average income tax valued and social 
security contributions by household type8. This variable has been PPP-adjusted, standardized by di-
viding through the square root of the household size and log transformed to achieve a normal distribu-
tion. To assess differences between groups of different health statuses, we use the number of chronic 
diseases as an objective health measure and additionally self-rated health which is measured on a 5 
point-scale. 
The following variables were introduced as controls. For gender and age we used different specifica-
tions in the logit and negative binomial models. In the logit models we include centered age measured 
in years, a gender dummy on the interaction term of both variables, for the negative binomials we 
added age2 and the according interaction term9. Furthermore, we included a variable that differenti-
ates between people who are employed or self-employed and people who are not employed (including 
the unemployed, homemakers, people who are permanently sick or disabled and retirees). Urban is 
used as a measure of regional inequality. Persons are coded 1 when they live in a big or large city, 
otherwise they got 0. Finally, we included two variables about the living arrangements of the respon-
dents. First, the dummy livtog indicates whether people live with a partner/spouse or as a single. 
Household size refers to the number of persons living in the household.  
Method 
Distributions of the number of doctor visits are usually characterized by overdispersion10 which makes 
the application of simple poisson models impossible (Jones 2000). The most widely used solution to 
this problem in doctor utilization research is the application of a two-step estimation procedure 
(Mullahy 1986; Pohlmeier and Ulrich 1995). This so-called hurdle model estimates in a first step 
whether people have any or no doctor visit and in a second step the number of doctor visits for the 
people with at least one visit. In this paper, we combined a logit model and a zero-truncated negative 
binomial. This is done by the application of a hurdle model. The probability of a zero is given by11: 
iiix
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      i = individual 
                                                     
8  We would like to thank Omar Paccagnella for providing us with the code for this procedure.  
9  For the specification of age, separate models were run for each of the six dependent variables for each of the 
eleven countries with six different age gender specifications: (1) gender, age (2) gender, age, gender*age (3) 
gender, age, age2 (4) gender, age, gender*age, age2, gender*age2 (5) age dummies (50-59,60-69,70-79, 
older as reference category) (6) age dummies + interactions of dummies with gender. Based on likelihood-
ratio-tests, AIC and BIC statistics the solution that worked best for the majority of countries was chosen. How-
ever, there were differences in the suitability of these specifications for each country which means that the 
comparability across countries decreases in some cases the parsimony of the model while in other cases the 
actual functional relationship is not captured.  
10  Overdispersion means that the variance exceeds the mean. This is a precondition for using a poisson distribu-
tion where equidispersion of mean and variance is assumed (Long and Freese 2006). 
11  In the analyses, we changed the coding for the outcome variable from predicting a zero to predicting not hav-
ing a zero (having any visit) for making interpretation clearer.  
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In the second step, the zero-truncated negative binomial includes only people who got past the zero 
hurdle which occurs with a probability of 1-π. Accordingly the conditional probability from the zero-
truncated model is weighted by this term:  
),0|1(Pr 1 iiii xyxy >−= π  for y > 0       i = individual 
(Long and Freese 2006: 387) 
By applying the hurdle model we predict enough zeros and therefore fit the empirical distribution of 
doctor visits. In addition, hurdle models allow studying seeing a doctor at all and the number of doctor 
visits as two different processes which allows using different explanatory variables. Empirical studies 
support the adequacy of hurdle models for estimating number of doctor-patient contacts (Pohlmeier 
and Ulrich 1995; Jiménez-Martin et al. 2002). As hurdle models can be estimated using maximum 
likelihood they have a computational advantage compared to more complex models such as finite 
mixture models (Deb and Trivedi 2006). The combination of empirical adequacy and computational 
simplicity made the hurdle model to our preferred analysis strategy12.  
The explanatory variables in our analysis are located on two levels. On the individual level, health 
status, education etc. are introduced in the analysis. On the country level, there are the institutional 
indicators measuring access regulations and provider supply. This combination of macro and micro 
level variables indicated a multilevel analysis strategy. On the one hand, a multilevel model allows to 
obtain estimates for the effects of the institutional indicators on the macro level. On the other hand, the 
multilevel model takes into account the nested data structure in the estimation of the standard errors.  
The two-level logit model is given by:  
)log(Pr 0111011000 jijjijjjijijij uXuXZZXxy +++++= γγγγ  u = error, i = individual, j = country 
(Hox 2002: 107) 
Due to the restricted number of countries, however, we used only very simple models, entering only 
two variables at a time and abstained from estimating cross-level interactions. Therefore interactions 
between micro and macro level variables were investigated graphically (see Equity Effects). As it was 
not possible for us to estimate a multi-level model for the number of doctor visits we used the following 
strategy. First, we estimated multi-level models for the zero hurdle which indicates, whether people 
have seen a doctor or not. Second, we estimated whether the institutional influence explain a more 
than an average use of visits (this refers to the mean across countries).  
                                                     
12  Some studies show that finite mixture models are superior to hurdle models (Deb and Trivedi 1997) but not in 
all applications (Winkelmann 2003). Winkelmann concludes that “this question still awaits a final answer” 
(p.147). A concrete test of model adequacy for our data and research question will be pursued in further ver-
sions.  
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Results 
This section consists of three parts. First, we will explore descriptively how countries differ in their 
average utilization of all medical doctor, GP and specialist visits. In a second part, multilevel analyses 
show how the regulation indices influence the overall amount of care that is consumed in a country. In 
a final part, we investigate how the institutional set-up affects differences in the utilization of services 
across groups with different income, educational level and health status.  
Descriptive Analyses 
Figure 3 shows the proportion of the population reporting at least one visit to a medical doctor, GP and 
specialist. On average, more than 85% of the population over 50 visited a doctor in the previous 12 
months.  
Figure 3: Proportion of population consulting any doctor, GP or specialist13 
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Note: average percentages, weighted.14 
Deviating from this average are Germany, France and Belgium where almost 93% of the respondents 
reported having seen a medical doctor, and Greece and Sweden with around 79% and 77%. When we 
look at GP and specialist visits we find important country differences, albeit on different levels. On 
average 80% of people over 50 visited a GP but across countries this proportion ranges from 89% in 
Belgium and France to 65% in Greece and Sweden. On average, the proportion of people who saw a 
specialist in the last year is much lower at 43% but again, we find considerable variation with figures 
from as low as 20% (Denmark) to as high as 58% (Germany). Overall, we can see that most of the 
                                                     
13  Abbreviations are as follows: AUT = Austria; BEL = Belgium; DNK = Denmark; FRA = France; DEU = Ger-
many; GRC = Greece; ITA = Italy; NLD = Netherlands; ESP = Spain; SWE = Sweden; CHE = Switzerland. 
14  All of the following descriptive and multivariate analyses are based on the SHARE data from 2004.  
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people have seen a general practitioner in the last 12 months but less than half have seen a specialist. 
In some countries specialist visits did occur only for a fifth of the respondents.  
Similar to the average percentages, large cross-country differences are found in the mean annual 
consultation rates shown in Figure 4. In high-use countries like Spain, Italy, Belgium, and Germany, 
the visit frequency is around 8 to 9.5 doctor visits per year, which is three times the number of Sweden 
(3) and twice the number of other low-use countries like Denmark (4.3) and the Netherlands (4.5). 
From the across-country average of 6.4 medical doctor visits, almost 5 visits have been to a general 
practitioner. Country-variation lies between less than two visits in Sweden to more than 7 visits in 
Spain and Italy. Both mean level and variation across countries is much lower for specialist visits 
where Germany leads with an average of 2.8 specialist visits and Denmark is at the bottom end with 
one specialist visit per year.  
Figure 4: Mean number of medical doctor, GP and specialist visits 
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Note: average percentages, weighted. 
Level Effects 
This section investigates whether the overall level of utilization of ambulatory healthcare is determined 
by the extent of legal access regulations and financial incentives. For this purpose multilevel models 
were estimated that include all micro level variables and the regulation indices. Sensitivity tests 
showed that the effects for the probability of any visits are highly sensitive to the case of Greece. 
Greece has a very fragmented national health system that is very weakly regulated by the state. How-
ever, consumption levels are kept low by the significance of informal payments and bribes which are 
not covered by the indicators introduced in our analyses. Greece was therefore excluded from the first 
three models which reduces the sample size from 26,808 to 24,183.  
Table 7 shows the effects of the overall level of regulation on the different visit types. Models 1 to 3 
show whether the regulation index has an effect on the likelihood of having at least one visit, models 4 
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to 6 instead show whether the degree of regulation affects the probability of having more than the 
average number of visits.  
The regulation index significantly reduces the probability of any visit independent of visit type and also 
the probability of having more than average specialist visits. The degree of overall access regulation 
explains between 59% and 22% in these models. The strongest effect is found for the probability of 
any medical doctor visit (Model 1). One unit increase on the regulation index decreases the odds of 
having any medical doctor visit by a factor of 0.87 (p < .001), holding all other variables constant. 
Model 2 looks at whether people had a GP visit in the previous year. A unit increase in the regulation 
index decreases the odds of having at least one GP visit by a factor of 0.9, holding all other variables 
constant (p < .01). The decrease in odds for having any specialist visit (model 3) is 0.92 (p < .1). The 
probability of having more than average doctor and GP visits is not significantly affected by the degree 
of access regulation. However, a unit increase in the regulation index, decreases the odds of having 
more than the average number of specialist visits by 0.95 (p<.1).  
Table 7: Multilevel models specifying effects of the regulation index 
 (1) (2) (3) (4) (5) (6) 
 Any-Doctor-
Model 
Any-GP-Model Any-Specialist 
Model 
Average-
Doctor Model 
Average-      
GP Model 
Average-
Specialist 
Model 
RI 0.873*** 0.901** 0.921+ 0.953 0.959 0.946+ 
 (0.03) (0.03) (0.04) (0.05) (0.05) (0.03) 
0.102 0.097 0.156 0.327 0.385 0.134 Country-Level 
Variance (0.05) (0.04) (0.07) (0.14) (0.17) (0.06) 
Explained 
Variance 
59% 47% 26% 8% 5% 22% 
N 24183 24183 24183 26808 26808 26808 
Note: Controlling for gender, centered age, gender*centered age, education, income, number of chronic condi-
tions, self assessed health status, employed, net income, urban residence, living with partner, household size; 
odds ratios; standard errors in parentheses; + p < .10, * p < .05, ** p < .01, *** p < .001. 
The legal regulation index investigates whether there is an independent effect of gatekeeping regimes 
on the number of doctor visits. We find that gatekeeping significantly affects the probability of any 
medical doctor and any GP visit. The influence is smaller than the combined effect of the regulation 
index and explains 42% of the variance in any doctor visit model and 23% in any GP visit model.  
Table 8: Multilevel models specifying effects of the legal regulation index 
 (1) (2) (3) (4) (5) (6) 
 Any-Doctor-
Model Any-GP-Model 
Any-Specialist 
Model 
Average-
Doctor Model 
Average-GP 
Model 
Average-
Specialist 
Model 
LRI 0.915** 0.945+ 0.945 0.969 0.978 0.956 
 (0.03) (0.03) (0.03) (0.04) (0.05) (0.03) 
0.145 0.141 0.168 0.340 0.398 0.142 Country-Level 
Variance (0.07) (0.06) (0.08) (0.15) (0.17) (0.06) 
Explained 
Variance 
42% 23% 21% 4% 2% 17% 
N 24183 24183 24183 26808 26808 26808 
Note: Controlling for gender, centered age, gender*centered age, education, income, number of chronic condi-
tions, self assessed health status, employed, net income, urban residence, living with partner, household size; 
odds ratios; standard errors in parentheses; + p < .10, * p < .05, ** p < .01, *** p < .001. 
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Finally, the effect of cost sharing, measured by the financial incentive index, was examined. We find 
that in a cross-national perspective cost sharing does not significantly affect the utilization of medical 
doctors (p > .1).  
Table 9: Multilevel models specifying effects of the financial incentive index 
 (1) (2) (3) (4) (5) (6) 
 Any-Doctor-
Model Any-GP-Model 
Any-Specialist 
Model 
Average-
Doctor Model 
Average-GP 
Model 
Average-
Specialist 
Model 
FII 1.011 0.990 1.012 0.985 0.977 0.998 
 (0.06) (0.05) (0.05) (0.06) (0.07) (0.04) 
0.250 0.183 0.211 0.353 0.402 0.171 Country-Level 
Variance  (0.11) (0.08) (0.10) (0.15) (0.17) (0.07) 
Explained 
Variance 
0% 1% 0% 1% 1% 0% 
N 24183 24183 24183 26808 26808 26808 
Note: Controlling for gender, centered age, gender*centered age, education, income, number of chronic condi-
tions, self assessed health status, employed, net income, urban residence, living with partner, household size; 
odds ratios; standard errors in parentheses; + p < .10, * p < .05, ** p < .01, *** p < .001. 
Equity Effects 
The institutional arrangement was not only hypothesized to influence the overall healthcare consump-
tion level in a country but also differences in utilization across groups. These were investigated by 
estimating country-specific hurdle models15. We hypothesized that in countries with low access regula-
tion, especially when it takes the form of gatekeeping, we should find higher differences in the utiliza-
tion of specialist care across groups with different educational levels than in countries with high regula-
tion. This is investigated in the following graphs by plotting the difference in predicted probabilities 
between groups with different educational levels over the regulation and the legal regulation index.  
In figure 5, we see the differences in the predicted probability of any specialist visit plotted over the 
regulation index. We see a slight a downwards trend (R = -.40) with the highest inequity in France, 
Germany and Greece. Belgium, Sweden, Austria and Denmark are more highly regulated and show 
also lower inequity levels. The Netherlands, Spain and Switzerland with a position on the regulation 
index between nine and ten have no significant differences in specialist utilization between people with 
and without college education. Italy clearly deviates from this pattern with a difference in utilization of 
.17 but the highest position on the regulation index.  
                                                     
15  Due to their size, they could not be included. They are available upon request.  
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Figure 5: Difference in predicted probability of having any specialist visit between people with 
and without college education over regulation index 
 
Source: SHARE 2004; under control of all micro-variables; Pearson’s R: -0.40. 
When we look at the same differences plotted over the legal regulation index we find a clearer down-
ward trend (R = .52). While in France where no gatekeeping features are introduced in the healthcare 
system people with college education have a 19 percentage points higher probability of a specialist 
visit than people without college education, this difference is in Denmark, a country with a strong gate-
keeping system, only 6 percentage points. Italy again deviates with a high inequity level despite a high 
level of legal regulation. In this graph, Switzerland also deviates which indicates that the exceptionally 
high cost sharing level in this country has a similar effect than the gatekeeping arrangements in other 
countries.  
Figure 6: Difference in predicted probability of having any specialist visit between people with 
and without college education over regulation index 
 
Source: SHARE 2004; under control of all micro-variables; Pearson’s R: -.0.52. 
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While the previous graphs showed how the highest educational group differs from the rest, we will now 
focus on differences between people with and without higher education. Higher education is here de-
fined as Isced groups 3 to 6 which include upper- and post-secondary as well as college education. 
This group is compared to persons with an educational level of pre-primary, primary or lower-
secondary education (Isced 0 to 2).  
In figure 7, we see a slight downward trend indicated by the linear prediction (R = -.32). However, 
when we exclude Italy as a deviating case from the linear prediction we can see a steep downward 
trend of educational inequity and the degree of access regulation (R = -.71). As in the graph compar-
ing people with and without college education, we find the highest educational inequity in specialist 
utilization in Greece, Germany and France which have the lowest position on the regulation index. We 
find a lower inequity in Belgium, Austria, Spain and Sweden and no significant differences in the Neth-
erlands, Switzerland and Denmark. Italy again deviates from the pattern with a difference in predicted 
probability of over .3 even though it is the most highly regulated country in the sample.  
Figure 7: Difference in predicted probability of having a specialist visit between people with 
and without higher education over regulation index 
 
Note: ─ linear prediction; ---- linear prediction without Italy.  
Source: SHARE 2004; under control of all micro-variables; Pearson’s R: -0.32; without Italy: -0.71. 
Figure 8 shows a similar downward trend (R = .70) with Italy as a deviating case. Overall these results 
suggest that countries with higher access regulations have lower inequity levels across groups with 
different levels of education.  
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Figure 8: Difference in predicted probability of having a specialist visit between people with 
and without higher education over legal regulation index 
 
Note: ─ linear prediction; ----linear prediction without Italy.  
Source: SHARE 2004; under control of all micro-variables; Pearson’s R: -0.37, without Italy: -0.70. 
The introduction of cost sharing measures is connected to a fear of increasing income inequity in 
health service utilization. Therefore we investigated how the level of income inequity for specialist 
visits is connected with our financial incentive index.  
In line with the results of van Doorslaer and colleagues (2000; 2004) most of the income inequity we 
found was for the probability of any specialist visit. While they did not systematically connect inequity 
and institutional indicators we come to the same conclusion that there is no relationship between the 
extent of income inequity and the degree of cost sharing in a country16. According to our analysis (not 
shown), the extent of income inequity is not related to the position of the financial incentive index with 
exception of the outstanding position of Switzerland on both measures. This might indicate that the 
effect of cost sharing might depend on a certain threshold. As long as this is not reached, there is no 
major effect on income inequity. It could also be an indication that the established protection mecha-
nisms in most countries are relatively effective in preventing income inequity.  
Vertical inequity refers to the question of how utilization differs between groups with different levels of 
need (“health status”). We hypothesized that gatekeeping reduces the use of inappropriate services 
and therefore increases efficiency. Empirically, this should be reflected by a lower utilization of people 
with better health status (H3).  
As empirical test for this hypothesis the probability of any medical doctor, GP and specialist visit is 
plotted over different health groups which are identified by the number of chronic illnesses and self-
rated health status. In this section, we only present paradigmatic graphs which illustrate the general 
                                                     
16  Using just out-of-pocket expenditures instead of the financial incentive index also shows no relationship.  
Arbei tspapiere -  Mannheimer  Zentrum für  Europäische Sozia l forschung 113  
 - 28 -
patterns found. The plots for all countries and all combinations of health and outcome variables are 
displayed in the appendix 10.  
Figure 9 and figure 10 show the probability of any medical doctor visit by the number of chronic ill-
nesses. Germany (LRI = 2.9) and France (LRI = 0) are used as paradigmatic cases for weakly regu-
lated countries, Denmark (LRI = 10) and Netherlands (LRI = 8.6) as highly regulated countries. Com-
paring the probability of any medical doctor visit by health groups across countries shows that the 
higher the degree of legal regulations, the higher is vertical inequity. In the weakly regulated countries 
France and Germany, for example, there are only small differences in the probability of any medical 
doctor visit between people with different numbers of chronic illnesses. Persons with no chronic illness 
already have a probability of more than 85% of having visited a medical doctor. In contrast to that the 
highly regulated countries Denmark and the Netherlands show a steep upwards trend across health 
groups. In these countries, the probability of any medical doctor visit for persons with no chronic ill-
ness is only around 70%. Also when we look at the point when the 100% mark is reached we see that 
in France and Germany this is the case between 2 and 3 chronic illnesses. In Denmark and the Neth-
erlands, however, this point is not reached before 4 or 5 chronic illnesses are diagnosed.  
Figure 9: Probability of any medical doctor visit by number of chronic illnesses:  
    weakly regulated countries 
     
Note: -- 95% confidence interval, weighted, all other variables at mean 
Figure 10: Probability of any medical doctor visit by number of chronic illnesses: 
  highly regulated countries 
     
Note: -- 95% confidence interval, weighted, all other variables at mean 
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The explained patterns can be found in similar form when self-rated health status instead of the num-
ber of chronic conditions is used as health measure and when any GP visit is used as outcome in-
stead of any medical doctor visit. The pattern described for Germany and France can be found in a 
similar way for Belgium and Switzerland and also in a less distinguished way for Austria. The pattern 
identified for the weakly regulated countries is also present in Italy and Sweden. Spain fits in the 
weakly regulated pattern for GP visits but shows low vertical equity for the probability of any medical 
doctor visit. Greece is again an outlier with a steep trend over health status but low regulation. 
The overall trend found fits into the formulated relationship of higher differences between health 
groups in higher regulated countries with some deviations such as Greece, Spain, and also Sweden 
which has higher vertical inequity than expected based on their modified gatekeeping system. With 
reference to specialist visits, there is no clear difference in the inequity across health groups. How-
ever, in line with the hypothesis we find that persons who are in good health have a much higher 
probability of having visited a specialist in weakly regulated countries than in highly regulated coun-
tries. While in Germany and France people without chronic illness had a probability of around 40% of 
having seen a specialist, in the Netherlands this probability was 30% and in Denmark only 15%.  
Figure 11: Probability of any specialist visit by number of chronic illnesses: weakly regulated 
countries 
       
Note: -- 95% confidence interval, weighted, all other variables at mean 
Figure 12: Probability of any specialist visit by number of chronic illnesses: highly regulated 
countries 
       
Note: -- 95% confidence interval, weighted, all other variables at mean 
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Taking these results together one can say that the extent of legal regulation certainly has an influence 
on the probability of people in good health status to see a doctor. In weakly regulated countries, peo-
ple in good health have a much higher likelihood of having seen any type of doctor than in highly regu-
lated countries. With reference to the probability of having any medical doctor or GP visit we also find 
that the difference in use between health groups is much smaller in weakly regulated countries than in 
highly regulated countries. 
Conclusion 
European health systems vary both in the degree and instruments used for regulating the access to 
healthcare. This paper investigated how gatekeeping and cost sharing arrangements as central ac-
cess regulation instruments affect the overall level of ambulatory healthcare utilization and inequity of 
utilization across different groups. 
Based on multilevel analyses with the SHARE dataset including 11 countries we found that the overall 
degree of access regulation indeed has a decreasing effect on the overall level of service utilization 
measured by the number of doctor visits. The effect was focused mainly on the probability of having 
any visit than on the number of visits. This fits in the idea of patient- and provider-initiated visits which 
assumes that the first visit in an illness spell is initiated by the patient, all further visits, however, might 
be strongly influenced by doctors’ recommendation and order. Since cost sharing and gatekeeping are 
mainly patient-focused access regulations our finding are in line with this conceptualization. 
Moreover, looking at country-specific regressions showed that access regulations also influence the 
inequity of care across population groups. We investigated inequity in specialist care both across 
groups with different income and educational level. While income inequity is not related to the degree 
of cost sharing as would be hypothesized, educational inequity is associated with the degree of ac-
cess regulation and especially the establishment of a gatekeeping system. Finally, we could show that 
a higher degree of regulation decreases the probability of a doctor visit for people with low need levels 
indicated by a good health status. This could be a sign for increased efficiency of these access regula-
tions since the take up rate of medical services by people in good health is lower. 
What are the policy implications of these results? The results indicate that access regulations can 
contribute to a reduction of health services used. However, the regulations mostly affect whether peo-
ple have a first doctor visit. This shows that an effective control of consumption levels has also to in-
fluence provider behavior. For instance, gatekeeping arrangements can be designed in a way that 
encourage efficient provider behavior such as fundholding schemes in Great Britain (Calnan et al. 
2006). In addition, putting the locus of responsibility in the GP also seems to have beneficial results in 
terms of increased equity across groups with different educational level. This finding supports theoreti-
cal assumptions about gatekeeping that have already influenced recent policy-making processes and 
debates in free-access countries. In 2005, France adopted a compulsory universal gatekeeping ar-
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rangement (Tiemann 2006). In Germany, sickness funds have to offer a gatekeeping model that the 
insured can join on a voluntary basis (Wasem et al. 2003). 
Our study had a specific focus on access regulations but that clearly does not capture the complexity 
of health system features that influence utilization of health services. Our indicators were not able to 
capture all of the important influence factors which was pointed out by Greece as deviating case. 
Greece is still characterized as “centralized, fragmented in terms of coverage, and quite far removed 
from its principles of equity and efficiency” (Davaki and Mossialos 2005: 143). This combination of 
underfunding of the public system and exclusion of benefits under certain insurance arrangements 
results in a particular importance of the private sector for providing service. Services obtained in the 
private sector, however, are related with informal payments and bribes (Davaki and Mossialos 2005). 
A second aspect that can explain the low number of visits is the shortage in GPs. This is due to the 
fact that training in general practice was not established until 1987 (Tragakes and Polyzos 1996). 
Moreover, primary care is unequally distributed in the country. A further limitation of the analyses is 
the small number of countries which does not allow estimating cross-level interactions as a better test 
of existing inequity patterns.  
The study, however, demonstrates that institutional indicators as access regulation are to be included 
in cross-country analyses that focus on differences in health service utilization by different groups of 
the population. Access regulation does not only reduce the level of utilization but also lowers inequality 
especially with regard to the utilization of specialist healthcare.  
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